Cart (0 Items)
Your cart is currently empty.
View Products
IP-free options
20+ years of experience with the most complex challenges
Extensive portfolio of techniques and technologies
Antibody engineering services for the most complex formats
-
Bispecific Antibodies services
- 8 weeks from sequence to bispecific production
- IP-conscious formats and mutations recommendations
- The widest bispecific format toolbox
-
Custom CAR-T cell development
- IP free
- High-diversity human cancer phage display libraries covering 18 types of cancer
-
Antibody-drug conjugate services
- >90% DAR homogeneity at the ratio you specify
- Broad variety of linkers and payloads
- 3 weeks from antibody to ADC
Every Tool You Need to Tackle Your Most Challenging Custom Antibody engineering projects
15 sub-types of bispecific antibodies to ensure your success
BiTE
Kλ-body
ScFv-(L)IgG
IgG-IgG
IgG(H)-ScFv
HSabody
F(ab’)2
Fab-ScFv
DVD-Ig
Duobody
Diabody
DART
CrossMab
Cross-X-Body
Move faster on your bispecific candidates with ProteoGenix. Fast-track expression and screening with our high-throughput antibody production platform — taking you from sequence to functional bispecific in as little as 8 weeks. Our bispecific antibody development service combines strategic experimental design with deep format expertise, so you get the best outcome, fast. And with access to the widest bispecific format toolbox on the market — including IP-free formats — you’re never locked in.
Discover better CAR-T Candidates with the world’s first human cancer phage display library
Accelerate your custom CAR-T cell development with our highly powerful phage-display cancer antibody library, built from patients across 18 cancer types. Pan directly on cells for physiologically relevant binder selection, and move from antigen design to CAR-T construct in just 6–10 weeks — with multiple validation steps built in for confidence at every stage.
Are you developing CAR-T therapy? Contact our Experts for guidance
Custom IP-conscious modifications to boost your antibody’s performance
Our experts engineer your antibody with your IP landscape in mind — from aglycosylation and half-life modulation to effector function tuning (ADCC, ADCP, CDC). We always provide IP-free alternatives and know how to navigate around patented mutations so you stay protected.
Need to label your diagnostic antibody? Just tell us your tag of choice and we handle the rest.
For your therapeutic project, we go from antibody to final ADC in just 3 weeks, with a broad choice of linkers and payloads including dual-drug designs. Expect >90% DAR homogeneity, with full flexibility over DAR value, distribution, drug location, and free drug percentage.
Smarter antibody engineering services for innovation without the guesswork
-
Our scientists thoroughly understand your project before designing any experiment, anticipating pitfalls and saving you from costly iterations, so you get it right the first time.
-
-
Related Services
FAQ
